See more : Icon Offshore Bhd (5255.KL) Income Statement Analysis – Financial Results
Complete financial analysis of Urologix, Inc. (ULGX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Urologix, Inc., a leading company in the Medical – Devices industry within the Healthcare sector.
- Antofagasta plc (ANTO.L) Income Statement Analysis – Financial Results
- Neurocrine Biosciences, Inc. (0K6R.L) Income Statement Analysis – Financial Results
- Bharat Bhushan Finance & Commodity Brokers Limited (BHARAT.BO) Income Statement Analysis – Financial Results
- H&R Real Estate Investment Trust (HR-UN.TO) Income Statement Analysis – Financial Results
- Shen’s Art Printing Co., Ltd. (8921.TWO) Income Statement Analysis – Financial Results
Urologix, Inc. (ULGX)
About Urologix, Inc.
Urologix, Inc. develops, manufactures, markets, and distributes minimally invasive medical products for the treatment of obstruction and symptoms due to benign prostatic hyperplasia (BPH) in the United States. The company offers Cooled ThermoTherapy, which produces targeted microwave energy combined with a cooling mechanism to protect healthy tissue and enhance patient comfort. It also provides Prostiva RF Therapy System that delivers radio frequency energy directly into the prostate to destroy prostate tissue, reduce constriction of the urethra, and relieve BPH symptoms. It serves patients and clinicians. Urologix, Inc. was founded in 1991 and is based in Minneapolis, Minnesota.
| Metric | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 14.24M | 16.59M | 17.03M | 12.57M | 14.77M | 12.82M | 14.91M | 21.32M | 25.89M | 25.81M | 24.32M | 18.78M | 22.74M | 15.34M | 8.16M | 6.10M | 11.20M | 5.50M | 400.00K | 500.00K |
| Cost of Revenue | 8.14M | 8.41M | 8.65M | 6.03M | 6.57M | 6.37M | 6.89M | 13.89M | 9.00M | 7.81M | 8.55M | 7.94M | 7.84M | 5.80M | 2.84M | 4.40M | 7.60M | 4.40M | 1.10M | 700.00K |
| Gross Profit | 6.09M | 8.18M | 8.38M | 6.54M | 8.20M | 6.45M | 8.01M | 7.42M | 16.89M | 18.00M | 15.78M | 10.83M | 14.90M | 9.53M | 5.32M | 1.70M | 3.60M | 1.10M | -700.00K | -200.00K |
| Gross Profit Ratio | 42.80% | 49.32% | 49.23% | 52.03% | 55.53% | 50.32% | 53.76% | 34.83% | 65.25% | 69.74% | 64.86% | 57.70% | 65.51% | 62.16% | 65.18% | 27.87% | 32.14% | 20.00% | -175.00% | -40.00% |
| Research & Development | 1.63M | 2.27M | 2.19M | 2.24M | 1.83M | 2.36M | 2.78M | 3.03M | 2.99M | 3.07M | 2.39M | 3.68M | 4.07M | 3.53M | 3.61M | 5.10M | 6.70M | 5.00M | 0.00 | 0.00 |
| General & Administrative | 2.30M | 2.52M | 3.39M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 5.85M | 7.72M | 7.03M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 8.15M | 10.23M | 10.42M | 8.01M | 8.60M | 8.53M | 11.77M | 11.09M | 12.94M | 11.64M | 12.34M | 15.39M | 12.05M | 10.80M | 8.77M | 10.90M | 9.10M | 5.70M | 7.00M | 5.50M |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 10.09M | 11.95M | 12.53M | 10.27M | 10.46M | 10.91M | 24.81M | 16.36M | 16.12M | 14.88M | 15.39M | 19.73M | 16.78M | 15.41M | 13.90M | 17.50M | 17.40M | 11.10M | 7.10M | 5.60M |
| Cost & Expenses | 18.23M | 20.35M | 21.17M | 16.30M | 17.03M | 17.28M | 31.70M | 30.25M | 25.12M | 22.69M | 23.94M | 27.67M | 24.63M | 21.22M | 16.74M | 21.90M | 25.00M | 15.50M | 8.20M | 6.30M |
| Interest Income | 0.00 | 0.00 | 0.00 | 1.00K | 0.00 | 53.00K | 400.00K | 554.00K | 371.00K | 147.00K | 110.00K | 0.00 | 495.00K | 993.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 693.00K | 555.00K | 482.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 9.00K | 53.00K | 0.00 | 261.00K | 247.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 587.00K | 674.00K | 695.00K | 565.00K | 793.00K | 973.00K | 1.19M | 2.26M | 2.02M | 1.88M | 2.00M | 1.69M | 1.76M | 1.95M | 1.51M | 1.50M | 1.60M | 400.00K | 100.00K | 100.00K |
| EBITDA | -6.34M | -3.05M | -3.46M | -3.16M | -1.46M | -3.44M | -15.21M | -6.12M | 2.78M | 5.15M | 2.70M | -5.94M | -126.00K | -3.93M | -7.06M | -14.30M | -10.90M | -11.40M | -7.90M | -6.00M |
| EBITDA Ratio | -3.37% | -18.85% | -20.26% | -25.15% | -9.91% | -27.25% | -36.32% | -31.30% | 10.76% | 19.39% | 8.99% | -31.61% | -0.55% | -25.64% | -86.49% | -234.43% | -97.32% | -207.27% | -1,975.00% | -1,200.00% |
| Operating Income | -6.93M | -3.92M | -4.15M | -3.73M | -2.26M | -4.47M | -16.80M | -8.93M | 769.00K | 3.12M | 585.00K | -10.17M | -1.89M | -5.88M | -8.57M | -15.80M | -13.80M | -10.00M | -7.80M | -5.80M |
| Operating Income Ratio | -48.68% | -23.64% | -24.34% | -29.64% | -15.28% | -34.84% | -112.69% | -41.90% | 2.97% | 12.10% | 2.41% | -54.17% | -8.29% | -38.35% | -105.04% | -259.02% | -123.21% | -181.82% | -1,950.00% | -1,160.00% |
| Total Other Income/Expenses | -694.00K | -356.00K | -495.00K | 1.00K | 0.00 | 53.00K | -9.79M | 554.00K | 371.00K | 138.00K | 97.00K | -1.28M | 0.00 | 0.00 | 0.00 | 0.00 | -1.30M | 1.80M | 200.00K | 300.00K |
| Income Before Tax | -7.62M | -4.28M | -4.64M | -3.73M | -2.26M | -4.41M | -16.40M | -8.38M | 1.14M | 3.26M | 785.00K | -11.45M | 0.00 | 0.00 | 0.00 | 0.00 | -15.10M | -8.20M | -7.60M | -5.50M |
| Income Before Tax Ratio | -53.56% | -25.79% | -27.25% | -29.63% | -15.28% | -34.43% | -110.01% | -39.30% | 4.40% | 12.63% | 3.23% | -60.96% | 0.00% | 0.00% | 0.00% | 0.00% | -134.82% | -149.09% | -1,900.00% | -1,100.00% |
| Income Tax Expense | -16.00K | 14.00K | 55.00K | 8.00K | -88.00K | 7.00K | -1.50M | 4.86M | -4.35M | 424.00K | -257.00K | 1.15M | -234.00K | -746.00K | -1.48M | -1.70M | 1.20M | -1.80M | -200.00K | -400.00K |
| Net Income | -7.61M | -4.29M | -4.70M | -3.73M | -2.17M | -4.42M | -14.90M | -13.24M | 5.49M | 2.84M | 642.00K | -10.05M | -1.65M | -5.14M | -7.10M | -14.10M | -15.00M | -8.20M | -7.60M | -5.40M |
| Net Income Ratio | -53.45% | -25.87% | -27.57% | -29.70% | -14.68% | -34.48% | -99.94% | -62.10% | 21.22% | 10.99% | 2.64% | -53.52% | -7.26% | -33.48% | -86.95% | -231.15% | -133.93% | -149.09% | -1,900.00% | -1,080.00% |
| EPS | -0.36 | -0.21 | -0.32 | -0.26 | -0.15 | -0.31 | -1.04 | -0.92 | 0.38 | 0.20 | 0.05 | -0.72 | -0.12 | -0.40 | -0.62 | -1.24 | -1.44 | -0.89 | -1.22 | -2.76 |
| EPS Diluted | -0.36 | -0.21 | -0.32 | -0.26 | -0.15 | -0.31 | -1.04 | -0.92 | 0.38 | 0.19 | 0.04 | -0.72 | -0.12 | -0.40 | -0.62 | -1.24 | -1.44 | -0.88 | -1.20 | -2.76 |
| Weighted Avg Shares Out | 21.22M | 20.70M | 14.74M | 14.56M | 14.51M | 14.39M | 14.34M | 14.33M | 14.32M | 14.28M | 14.02M | 13.92M | 13.81M | 12.76M | 11.51M | 11.35M | 10.43M | 9.17M | 6.24M | 1.96M |
| Weighted Avg Shares Out (Dil) | 21.22M | 20.70M | 14.74M | 14.56M | 14.51M | 14.39M | 14.34M | 14.33M | 14.37M | 14.76M | 14.65M | 13.92M | 13.81M | 12.76M | 11.51M | 11.39M | 10.43M | 9.30M | 6.33M | 1.96M |
Source: https://incomestatements.info
Category: Stock Reports